Cargando…
Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients)
OBJECTIVE: Triple negative breast cancer is an aggressive variant of breast cancer; it forms about 15% of breast cancer cases. It lacks the responsiveness to hormonal and targeted therapies. Anthracyclines remain the treatment option for these patients. Anthracyclines are cardiotoxic, so predicting...
Autores principales: | Eltohamy, Mahitab Ibrahim, Badawy, Omnia Mohammed, kinaai, Naglaa El, Loay, Iman, Nassar, Hanan Ramadan, Allam, Rasha Mahmoud, Sakr, Mona Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428522/ https://www.ncbi.nlm.nih.gov/pubmed/30583686 http://dx.doi.org/10.31557/APJCP.2018.19.12.3581 |
Ejemplares similares
-
The outcome of early-stage glottic carcinoma patients treated with radiotherapy: Egyptian National Cancer Institute (NCI-Egypt) experience
por: Mohamed, Aisha Elsayed, et al.
Publicado: (2023) -
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
por: Marinello, Jessica, et al.
Publicado: (2018) -
Menogaril, an Anthracycline Derivative, Inhibits DNA Topoisomerase II by Stabilizing Cleavable Complexes
por: Ono, Katsuhiro, et al.
Publicado: (1992) -
Association of rs1544410 and rs7975232 Polymorphisms and Serum Vitamin D Levels with Psoriasis Susceptibility and Severity: A Case–Control Study in Egyptian Patients
por: Mohamed, Amal Ahmed, et al.
Publicado: (2022) -
CMV, B and C hepatitis among multi-transfused hereditary hemolytic Anemia children: an updated Egyptian experience
por: Sherief, Laila M., et al.
Publicado: (2021)